✦ LIBER ✦

Allergy in chronic haemodialysis. 1. Double-blind intravenous challenge with formaldehyde

✍ Scribed by J. BOUSQUET; J.-P. RIVORY; F. MAURICE; W. SKASSA-BROCIEK; P. LARRSON; S. G. O. JOHANSSON; P. FLORENCE; F. B. MICHEL

Book ID: 108683031
Publisher: John Wiley and Sons
Year: 1987
Tongue: English
Weight: 509 KB
Volume: 17
Category: Article
ISSN: 0954-7894
DOI: 10.1111/j.1365-2222.1987.tb02045.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Double-blind challenge tests with food a

Double-blind challenge tests with food additives in chronic urticaria

✍ J.K. Kellett; P.J. August; M.H. Beck 📂 Article 📅 1984 🏛 John Wiley and Sons 🌐 English ⚖ 75 KB

Double-blind placebo-controlled peroral

Double-blind placebo-controlled peroral challenges in patients with delayed-type allergy to balsam of Peru

✍ Aila Niinimäki 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 933 KB

Phase 1B, randomized, double-blind, dose

Phase 1B, randomized, double-blind, dose-escalation trial of CPG 10101 in patients with chronic hepatitis C virus

✍ John G. McHutchison; Bruce R. Bacon; Stuart C. Gordon; Eric Lawitz; Mitchell Shi 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 397 KB 👁 1 views

CPG 10101, a synthetic oligodeoxynucleotide (ODN), is a toll-like receptor 9 (TLR9) agonist with antiviral and immunomodulatory properties that could potentially influence chronic infection with HCV. In this multicenter Phase 1b trial, 60 HCV-positive patients (50 genotype 1 HCV) were randomized and

Telbivudine versus lamivudine in Chinese

Telbivudine versus lamivudine in Chinese patients with chronic hepatitis B: Results at 1 year of a randomized, double-blind trial

✍ Jinlin Hou; You-Kuan Yin; Daozhen Xu; Deming Tan; Junqi Niu; Xiaqiu Zhou; Yuming 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 179 KB

Chronic hepatitis B and its life-threatening sequelae are highly prevalent in China. There is a need for effective new therapies to suppress hepatitis B virus (HBV) replication and ameliorate liver disease. In this study, we compared the efficacy of telbivudine, a nucleoside analogue, with lamivudin

Randomised clinical trial: the efficacy

Randomised clinical trial: the efficacy of prucalopride in patients with chronic intestinal pseudo-obstruction – a double-blind, placebo-controlled, cross-over, multiple n = 1 study

✍ A. V. Emmanuel; M. A. Kamm; A. J. Roy; R. Kerstens; L. Vandeplassche 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 244 KB

Final results of a double-blind, placebo

Final results of a double-blind, placebo-controlled trial of the antifibrotic efficacy of interferon-γ1b in chronic hepatitis C patients with advanced fibrosis or cirrhosis

✍ Paul J. Pockros; Lennox Jeffers; Nezam Afdhal; Zachary D. Goodman; David Nelson; 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 383 KB 👁 2 views

## Interferon-␥1b (IFN-␥1b ) is a pleiotropic cytokine that displays antifibrotic, antiviral, and antiproliferative activity. A total of 502 patients with compensated liver disease and an Ishak fibrosis score of 4-6 were randomized in a double-blind, placebo-controlled study, and 488 of these pati